Dace L. Trence MD, MACE
Professor Emeritus, Department of Medicine, Division of Metabolism, Endocrinology, and Medicine, University of Washington, Seattle, WashingtonDace L. Trence, MD, MACE, is Professor Emeritus, Department of Medicine, in the Division of Metabolism, Endocrinology, and Nutrition at the University of Washington in Seattle, Washington. Currently, she is Program Director of the Endocrinology Fellowship at the University of Washington. She is also the immediate past Director of Endocrine Days Educational Institute- which provides CME to endocrinologists in community and academic practice in the Pacific Northwest, and past editor of Empower Magazine, AACE’s ( American Association of Clinical Endocrinology) informational magazine relating to hormonal and metabolic issues, targeted to the lay population. She has published in a number of endocrine journals, including Endocrine Practice, JCEM, Diabetes Care, and Diabetes Educator. She received AACE’s Outstanding Clinical Endocrinologist Award in 2014, and MACE award in 2019.
Disclosures
Dr. Trence has no relevant disclosures.Recent Contributions to PracticeUpdate:
- Efficacy and Safety of Ultra–Rapid Acting vs Rapid-Acting Insulin Analogs in People With Type 1 or Type 2 Diabetes
- Weekly Icodec vs Daily Glargine U100 for Insulin-Naïve Type 2 Diabetes
- Discontinuing CGM in Type 2 Diabetes With Basal Insulin Treatment
- Insulin Degludec and Glargine U100 Treatment in T1D Patients Prone to Nocturnal Severe Hypoglycaemia
- Continuous Glucose Monitoring Metrics in Persons Treated With Multiple Daily Insulin Injections
- Once-Weekly Insulin for T2DM Without Past Insulin Therapy
- Regular U-500 Insulin via Continuous Subcutaneous Infusion vs Multiple Daily Injections in Adults With Type 2 Diabetes